Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Alpinyl.

Client Email

Product

Alpinyl
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Paracetamol

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Alpinyl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

116 API Suppliers, 80 USDMF, 22 CEP/COS, 16 JDMF, 7 EU WC, 108 KDMF, 107 NDC API, 30 Listed Suppliers, $ API Reference Price

116 API Suppliers
80 USDMF
22 CEP/COS
16 JDMF
7 EU WC
108 KDMF
107 NDC API
30 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

2528 FDF Dossiers, 729 FDA Orange Book, 503 Europe, 290 Canada, 75 Australia, 402 South Africa, 529 Listed Dossiers

2528 FDF Dossiers
729 FDA Orange Book
503 Europe
290 Canada
75 Australia
402 South Africa
529 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

SUPPOSITORY;RECTAL - 120MG
SUPPOSITORY;RECTAL - 325MG
SUPPOSITORY;RECTAL - 650MG
SUPPOSITORY;RECTAL - 80MG
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 250MG;250MG;65MG
TABLET;ORAL - 325MG;37.5MG
SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG;15MG
TABLET;ORAL - 300MG;30MG
TABLET;ORAL - 300MG;60MG
TABLET;ORAL - 325MG;5MG
TABLET;ORAL - 325MG;50MG;40MG
TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 1 Evonik, 14 Rochem International Inc, 31 SPI Pharma, 2 Seqens, 32 DKSH, 3 Jai Radhe Sales, 3 Pharm-RX Chemical, 14 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 18 Gangwal Healthcare, 22 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 19 Actylis, 3 Aeon Procare, 4 Alcedo Pharmachem, 13 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 44 BASF, 8 Beneo, 2 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 4 Finar, 17 Gangwal Chemicals, 2 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 27 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 13 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 22 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 4 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

146 Fillers, Diluents & Binders, 81 Thickeners and Stabilizers, 71 Solubilizers, 69 Coating Systems & Additives, 62 Direct Compression, 60 Taste Masking, 54 Topical, 50 Disintegrants & Superdisintegrants, 46 Parenteral, 40 Controlled & Modified Release, 40 Lubricants & Glidants, 40 Film Formers & Plasticizers, 40 Granulation, 27 Chewable & Orodispersible Aids, 26 Emulsifying Agents, 24 Co-Processed Excipients, 18 Rheology Modifiers, 15 Surfactant & Foaming Agents, 13 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

146 Fillers, Diluents & Binders
81 Thickeners and Stabilizers
71 Solubilizers
69 Coating Systems & Additives
62 Direct Compression
60 Taste Masking
54 Topical
50 Disintegrants & Superdisintegrants
46 Parenteral
40 Controlled & Modified Release
40 Lubricants & Glidants
40 Film Formers & Plasticizers
40 Granulation
27 Chewable & Orodispersible Aids
26 Emulsifying Agents
24 Co-Processed Excipients
18 Rheology Modifiers
15 Surfactant & Foaming Agents
13 API Stability Enhancers
9 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

13 DATA COMPILATION #PharmaFlow, 339 NEWS #PharmaBuzz

13 DATA COMPILATION #PharmaFlow
339 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 406 Finished Drug Prices, 20 Annual Reports

7 US Medicaid Prescriptions
406 Finished Drug Prices
20 Annual Reports

MARKET PLACE

173 APIs, 95 FDF Dossiers

173 APIs
95 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 2 US Exclusivities, 3 Health Canada Patents

41 US Patents
2 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 7 USP, 1 JP, 26 Others

1 EDQM
7 USP
1 JP
26 Others

ANALYTICAL

2 BioAnalytical Methods, 8 Analytical Methods

2 BioAnalytical Methods
8 Analytical Methods

$ API Ref.Price (USD/KG) : 7 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1Mallinckrodt Canada

02 2Mallinckrodt Pharmaceuticals Inc

filter Patent Reset all filters

3 All

01 12233924

02 12415403

03 12705733

filter Product Reset all filters

3 All

01 3Acetaminophen

filter Dosage Reset all filters

3 All

01 3Solution

filter Exp Date Reset all filters

3 All

01 12017-08-05

02 12021-06-06

03 12028-11-13

Granules Paracetamol

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

01

Mallinckrodt Pharmaceuticals Inc

Paracetamol

Formnext Forum

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Paracetamol

Brand Name : OFIRMEV?

Patent Number : 2415403

Filing Date : 2001-06-06

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Mallinckrodt Canada

Paracetamol

Formnext Forum

Not Confirmed

Mallinckrodt Canada

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Paracetamol

Brand Name : OFIRMEV?

Patent Number : 2233924

Filing Date : 1997-08-05

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Mallinckrodt Pharmaceuticals Inc

Paracetamol

Formnext Forum

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Paracetamol

Brand Name : OFIRMEV?

Patent Number : 2705733

Filing Date : 2008-11-13

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?